A

Amylyx Pharmaceuticals

Biopharmaceutical company developing neurodegenerative therapies

Director – Intellectual Property

Intellectual Property (IP)Confirmed live in the last 24 hours
Full-timeRemote in USA

About the Job

Requirements

  • At least 10 years of overall experience, ideally including at least 7 years of demonstrated patent-matters experience in the pharmaceutical or biotechnology industries and at least 5 years of law-firm experience.
  • A J.D. degree, membership in good standing of at least one state bar, and registration to practice before the U.S. Patent and Trademark Office.
  • An advanced degree, such as an M.S. or Ph.D., or equivalent industry experience in chemistry, biochemistry, biology, or another life-science-related discipline.
  • Significant demonstrated patent experience in pharmaceutical or biotechnology therapeutics, such as small molecules, peptides, oligonucleotides, proteins, or biologic therapeutics.
  • Experience supporting or managing Hatch-Waxman patent litigation, litigation readiness efforts, and/or inter partes reviews.
  • Experience advising on regulatory exclusivities, such as new-chemical entity, orphan drug, and pediatric exclusivity, as well as patent term extensions.
  • Experience conducting patentability, freedom-to-operate, due diligence, and validity assessments.
  • Global patent prosecution experience, including drafting patent applications and handling day-to-day prosecution tasks.
  • Ability to deliver solution-focused, fit-for-purpose guidance on complex matters, drive initiatives and cross-functional alignment, and influence the organization.

Responsibilities

  • Lead strategic patent portfolio development and litigation-readiness strategies for assigned clinical and pipeline molecules.
  • Support efforts to pursue regulatory exclusivities, such as pediatric exclusivity and orphan drug exclusivity.
  • Perform IP assessments, including IP diligence supporting business-development efforts, freedom-to-operate, patentability, validity, and competitive intelligence, as assigned.
  • Monitor IP case law and policy developments, advise on their impact, and develop best practices and risk-mitigation strategies.
  • Support transactions, including drafting and directly negotiating IP-related contractual terms for license, collaboration, manufacturing, clinical-development, and R&D contracts; advise stakeholders on post-execution impact and compliance with IP contractual terms.
  • Manage day-to-day patent prosecution for assigned clinical and pipeline molecules, including drafting patent applications and managing U.S. and non-U.S. outside counsel.
  • Monitor R&D, clinical, and manufacturing activities to identify potential IP-protection opportunities; review proposed publications, presentations, and other public releases for alignment with patent strategy.
  • Manage the global trademark portfolio through outside counsel and perform clearance assessments as needed.

Desired Qualifications

  • A Ph.D. in a life-science-related discipline.
  • Experience structuring, drafting, and negotiating IP-related aspects of license, collaboration, R&D, manufacturing, and/or clinical-development contracts.
  • Patent experience on both the brand and generic sides of therapeutics.
  • Trademark prosecution experience.

About the Company

Amylyx Pharmaceuticals

Biopharmaceutical company developing neurodegenerative therapies

Amylyx Pharmaceuticals develops treatments for neurodegenerative diseases, with a focus on ALS and Alzheimer's disease. Its main asset is AMX0035, currently in clinical trials, including the CENTAUR study for ALS and the PEGASUS study for late mild cognitive impairment or early dementia due to Alzheimer’s disease. The company advances products through rigorous, randomized, double-blind, placebo-controlled trials to demonstrate safety and efficacy before pursuing commercialization. In addition to research, Amylyx engages in awareness and community campaigns to support patients, caregivers, and researchers. The company aims to bring validated therapies to market to improve patient outcomes and generate revenue by selling treatments to healthcare providers and patients.

Company size
51-200
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2013

Recently Posted Jobs

Explore more opportunities at Amylyx Pharmaceuticals

See more jobs